Clinical trial
Evaluating the Impact of Incremental Doses of a Sugar Replacer Blend on Gastrointestinal Tolerance in Chocolate
NCT06479330 is registered in ClinicalTrials.gov with Mondelēz International, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Impact of Incremental Doses of a Sugar Replacer Blend on Gastrointestinal Tolerance in Chocolate
- Lead sponsor
- Mondelēz International, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 9, 2024
- Completion date
- December 20, 2024
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gastrointestinal tolerance, healthy population